ATON PHARMA INC has a total of 52 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are AKCIJU SABIEDRIBA OLAINFARM, METABOLIC SOLUTIONS DEV CO LLC and CELLTAXIS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | Canada | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | China | 6 | |
#5 | United States | 5 | |
#6 | Brazil | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Australia | 1 | |
#9 | Ecuador | 1 | |
#10 | Israel | 1 | |
#11 | Iceland | 1 | |
#12 | Mexico | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Name | Total Patents |
---|---|---|
#1 | Miller Thomas A | 27 |
#2 | Richon Victoria M | 19 |
#3 | Witter David J | 14 |
#4 | Belvedere Sandro | 13 |
#5 | Bacopoulos Nicholas G | 12 |
#6 | Chiao Judy H | 12 |
#7 | Paradise Carolyn M | 12 |
#8 | Halloran Kevin John | 7 |
#9 | Wells Michael | 5 |
#10 | Jacob Jean Theresa | 5 |
Publication | Filing date | Title |
---|---|---|
WO2011053835A1 | Stereoselective synthesis of metyrosine | |
CA2779104A1 | Ocular drug delivery devices | |
CN101820870A | Uses of trientine and penicillamine as countermeasures to metal contamination | |
CA2561617A1 | Histone deacetylase inhibitor prodrugs | |
WO2005053610A2 | Diamine and iminodiacetic acid hydroxamic acid derivatives | |
CA2543319A1 | Methods of treating leukemia with suberoylanilide hydroxamic acid | |
CN1901902A | Thiophene and benzothiophene hydroxamic acid derivatives | |
CN1870985A | Methods of treating cancer with HDAC inhibitors | |
WO2005023179A2 | Combination methods of treating cancer | |
KR20080041307A | Methods of inducing terminal differentiation |